comparemela.com

Latest Breaking News On - Dietmar berger - Page 5 : comparemela.com

Press Release: Sarclisa® (isatuximab) Phase 3 trial met

Press Release: Sarclisa® (isatuximab) Phase 3 trial met
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Paris
France-general
France
Dietmar-berger
Tarik-elgoutni
Felix-lauscher
Eva-schaefer-jansen
Sally-bain
Nathalie-pham
Corentine-driancourt
Thierry-facon
Lille-university-hospital

Sanofi multiple myeloma drug shows potential in newly diagnosed cases (NASDAQ:SNY)

Sanofi multiple myeloma drug shows potential in newly diagnosed cases (NASDAQ:SNY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Dietmar-berger

Sanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage Trial

By Adria Calatayud Sanofi said a late-stage clinical trial for its Sarclisa drug in combination with other drugs met its primary goal of progression-free survival in patients with newly.

France
French
Dietmar-berger
Adria-calatayud
Dow-jones
Markets

Sanofi - Aventis Groupe: Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant

Sanofi - Aventis Groupe: Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France
Paris
France-general
Thierry-facon
Corentine-driancourt
Felix-lauscher
Tarik-elgoutni
Nathalie-pham
Sally-bain
Eva-schaefer-jansen
Stefan-klotter
Dietmar-berger

vimarsana © 2020. All Rights Reserved.